Clinical trials
Completed Mucopolysaccharidosis III trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shire | 4 |
| Alexion Pharmaceuticals, Inc. | 3 |
| Allievex Corporation | 2 |
| LYSOGENE | 2 |
| Masonic Cancer Center, University of Minnesota | 2 |
| Swedish Orphan Biovitrum | 2 |
| University of Minnesota | 2 |
| Lynda E Polgreen | 1 |
| Nationwide Children's Hospital | 1 |
| Phoenix Nest | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mucopolysaccharidosis III | 24 |
| Mucopolysaccharidoses | 7 |
| Genetic Diseases, Inborn | 4 |
| Lysosomal Storage Diseases | 4 |
| Metabolic Diseases | 4 |
| Leukodystrophy, Globoid Cell | 3 |
| Metabolism, Inborn Errors | 3 |
| Mucopolysaccharidosis I | 3 |
| Mucopolysaccharidosis II | 3 |
| Adrenoleukodystrophy | 2 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.